Alps ALPS

Alps Group Inc is an exempted company incorporated under the laws of the Cayman Islands on May 14 2024. The company was formed specifically to complete a Business Combination. Prior to the Business Combination Alps Group Inc had no independent operations and was considered a shell company. Following the consummation of the Business Combination the business of Alps Life Sciences Inc and Alps Global Holding Berhad and their subsidiaries became the business of Alps Group Inc. As a result all of the company’s operations are conducted through its subsidiaries. The registered office of Alps Group Inc is located at c o Ogier Global (Cayman) Limited 89 Nexus Way Camana Bay Grand Cayman Cayman Islands. The principal executive office is situated at Unit E 18 01 and E 18 02 Level 18 Icon Tower (East) No 1 Jalan 1 68F Jalan Tun Razak 50400 Kuala Lumpur Wilayah Persekutuan Malaysia. The company maintains a website whose address is provided in the filing but the information on that site is not incorporated into this report. The entity is referred to as the Combined Company in the Shell Company Report filed with the SEC. The SEC maintains an Internet site where reports and other information about issuers are available at www dot sec dot gov.

Alps Group Inc generates revenue through the business activities of its subsidiaries Alps Life Sciences Inc and Alps Global Holding Berhad. The company does not produce goods or provide services directly; instead it consolidates the financial results of its operating entities. Revenue streams arise from the life sciences related operations of Alps Life Sciences Inc and from the holding and investment activities of Alps Global Holding Berhad. The consolidated financial statements of Alps Group Inc reflect the combined performance of these two business units. Alps Life Sciences Inc is engaged in the research development and commercialization of life sciences products and services. Alps Global Holding Berhad is engaged in the acquisition management and disposition of interests in various enterprises. The company’s total revenue is therefore derived from the combined operations of its life sciences and holding subsidiaries.

Alps Group Inc participates in the life sciences industry through its subsidiary Alps Life Sciences Inc and in the holding and investment sector through Alps Global Holding Berhad. The life sciences industry encompasses companies engaged in research development manufacturing and distribution of pharmaceuticals medical devices and diagnostic products. The holding and investment sector consists of entities that acquire manage and divest interests in other businesses to create value for shareholders. By holding interests in both sectors Alps Group Inc benefits from diversification across complementary business areas. The life sciences sector is subject to rigorous regulatory oversight and requires substantial investment in research and development. Companies in the holding and investment sector often seek to generate returns through strategic acquisitions and efficient capital deployment. Alps Group Inc’s dual exposure allows it to balance potential growth opportunities with stable income streams.

The company’s customer base comprises the clients of its subsidiaries Alps Life Sciences Inc and Alps Global Holding Berhad. Alps Life Sciences Inc serves healthcare providers research institutions patients and other organizations involved in the life sciences field. Alps Global Holding Berhad serves investors corporate clients and partners seeking exposure to diversified holdings. Customers of the life sciences subsidiary may include hospitals clinics laboratories and biotechnology firms. Customers of the holding subsidiary may include institutional investors private equity firms and corporate treasury departments. The company relies on its subsidiaries to maintain relationships with these diverse customer groups.